Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kairos Pharma (KAPA) Non Operating Income (2024 - 2025)

Kairos Pharma (KAPA) has disclosed Non Operating Income for 2 consecutive years, with $34000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Non Operating Income rose 230.77% year-over-year to $34000.0, compared with a TTM value of -$160000.0 through Jun 2025, changed N/A, and an annual FY2024 reading of -$260000.0, down 165.31% over the prior year.
  • Non Operating Income was $34000.0 for Q2 2025 at Kairos Pharma, up from $4000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $466000.0 in Q4 2024 and bottomed at -$664000.0 in Q3 2024.